Gamco Investors INC. ET AL Lowers Stock Position in PetIQ, Inc. (NASDAQ:PETQ)

Gamco Investors INC. ET AL lessened its holdings in PetIQ, Inc. (NASDAQ:PETQ) by 1.8% during the first quarter, Holdings Channel.com reports. The firm owned 68,465 shares of the company’s stock after selling 1,223 shares during the quarter. Gamco Investors INC. ET AL’s holdings in PetIQ were worth $1,252,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC purchased a new stake in PetIQ in the 4th quarter valued at approximately $35,000. FinTrust Capital Advisors LLC boosted its stake in shares of PetIQ by 50.2% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,618 shares of the company’s stock worth $48,000 after acquiring an additional 875 shares in the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of PetIQ during the 4th quarter worth approximately $50,000. AJOVista LLC purchased a new stake in shares of PetIQ during the 4th quarter worth approximately $65,000. Finally, China Universal Asset Management Co. Ltd. boosted its stake in shares of PetIQ by 351.4% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 3,372 shares of the company’s stock worth $67,000 after acquiring an additional 2,625 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

PetIQ Price Performance

Shares of PetIQ stock traded up $0.44 during trading on Friday, hitting $21.89. 191,088 shares of the company were exchanged, compared to its average volume of 310,463. The company has a quick ratio of 1.25, a current ratio of 2.42 and a debt-to-equity ratio of 1.84. PetIQ, Inc. has a fifty-two week low of $15.09 and a fifty-two week high of $22.98. The stock has a market capitalization of $651.23 million, a price-to-earnings ratio of 99.50 and a beta of 1.71. The firm has a 50 day moving average price of $21.56 and a 200 day moving average price of $19.03.

PetIQ (NASDAQ:PETQ) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.34 by $0.17. PetIQ had a return on equity of 13.33% and a net margin of 0.66%. The firm had revenue of $308.44 million during the quarter, compared to the consensus estimate of $302.16 million. On average, equities analysts expect that PetIQ, Inc. will post 1.1 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Scott Huff sold 12,117 shares of PetIQ stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $22.19, for a total transaction of $268,876.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 9.62% of the company’s stock.

Analysts Set New Price Targets

Separately, Benchmark reissued a “buy” rating and set a $30.00 price target on shares of PetIQ in a research note on Friday, May 10th. Four equities research analysts have rated the stock with a buy rating, According to MarketBeat, PetIQ presently has an average rating of “Buy” and an average price target of $29.00.

PetIQ Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.